Position in INSM
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$17,053,500
+$1,557,849 QoQ
Shares Held
104,290
+17.1% QoQ
Ownership
0.048%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2024
7 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in INSM Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026VAN ECK ASSOCIATES CORP holds $332,748,136 across 30 Biotechnology names. INSM ranks #6 (5.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
146,116 | $65,246,638 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
62,584 | $48,354,901 | |
| 3 | ONC |
BeOne Medicines Ltd.
|
108,305 | $32,163,335 | |
| 4 | ARGX |
Argenx SE
|
40,397 | $29,499,909 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
54,137 | $17,912,308 | |
| 6 | INSM |
INSMED Inc
This page
|
104,290 | $17,053,500 | |
| 7 | TECH |
BIO-TECHNE Corp
|
317,198 | $16,576,767 | |
| 8 | MRNA |
Moderna, Inc.
|
246,431 | $12,518,694 |
All Filings in INSM
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $17,053,500 | 104,290 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $15,495,651 | 89,035 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $15,366,155 | 106,702 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $12,055,263 | 119,786 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $9,425,782 | 123,552 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $8,231,915 | 119,234 | Shares | Sole | 2025-01-29 | |
| 2024-09-30 | $9,272,752 | 127,024 | Shares | Sole | 2024-10-29 | |
| No filing history on record for this holder in this stock. | ||||||